Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabine.
Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabine. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):131-8.